| A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal … R Narayanan, B Panchal, T Das, J Chhablani, S Jalali, MH Ali British Journal of Ophthalmology 99 (7), 954-959, 2015 | 127 | 2015 |
| Pharmacokinetics of intravitreal antibiotics in endophthalmitis M Radhika, K Mithal, A Bawdekar, V Dave, A Jindal, N Relhan, T Albini, ... Journal of ophthalmic inflammation and infection 4, 1-9, 2014 | 82 | 2014 |
| Endophthalmitis following pars plana vitrectomy: a literature review of incidence, causative organisms, and treatment outcomes VP Dave, A Pathengay, SG Schwartz, HW Flynn Jr Clinical Ophthalmology, 2183-2188, 2014 | 58 | 2014 |
| Trends in microbiological spectrum of endophthalmitis at a single tertiary care ophthalmic hospital in India: a review of 25 years J Joseph, B Sontam, SJM Guda, J Gandhi, S Sharma, M Tyagi, VP Dave, ... Eye 33 (7), 1090-1095, 2019 | 51 | 2019 |
| Clinical and microbiologic review of culture-proven endophthalmitis caused by multidrug-resistant bacteria in patients seen at a tertiary eye care center in southern India A Pathengay, MR Moreker, R Puthussery, S Ambatipudi, S Jalali, AB Majji, ... Retina 31 (9), 1806-1811, 2011 | 48 | 2011 |
| Efficacy of anti–vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2 R Narayanan, J Chhablani, M Sinha, V Dave, M Tyagi, RR Pappuru, ... Retina 32 (10), 2001-2005, 2012 | 47 | 2012 |
| Clinical presentations, risk factors and outcomes of ceftazidimeresistant Gramnegative endophthalmitis VP Dave, A Pathengay, K Nishant, RR Pappuru, S Sharma, P Sharma, ... Clinical & experimental ophthalmology 45 (3), 254-260, 2017 | 43 | 2017 |
| Infectious endophthalmitis leading to evisceration: spectrum of bacterial and fungal pathogens and antibacterial susceptibility profile TV Dave, VP Dave, S Sharma, R Karolia, J Joseph, A Pathengay, ... Journal of Ophthalmic Inflammation and Infection 9, 1-5, 2019 | 38 | 2019 |
| Endophthalmitis after pars plana vitrectomy: clinical features, risk factors, and management outcomes VP Dave, A Pathengay, S Basu, N Gupta, S Basu, V Raval, T Das, ... Asia-Pacific Journal of Ophthalmology 5 (3), 192-195, 2016 | 37 | 2016 |
| Aspergillus endophthalmitis: clinical presentations and factors determining outcomes VP Dave, RR Pappuru, A Pathengay, R Gupta, J Joseph, S Sharma, ... The Asia-Pacific Journal of Ophthalmology 9 (1), 9-13, 2020 | 35 | 2020 |
| Folic acid modified gold nanoparticle for targeted delivery of Sorafenib tosylate towards the treatment of diabetic retinopathy V Dave, R Sharma, C Gupta, S Sur Colloids and Surfaces B: Biointerfaces 194, 111151, 2020 | 34 | 2020 |
| Hybrid nanoparticles for the topical delivery of norfloxacin for the effective treatment of bacterial infection produced after burn V Dave, K Kushwaha, RB Yadav, U Agrawal Journal of microencapsulation 34 (4), 351-365, 2017 | 30 | 2017 |
| Targeted high-throughput sequencing identifies predominantly fungal pathogens in patients with clinically infectious, culture-negative endophthalmitis in South India J Gandhi, R Jayasudha, P Naik, S Sharma, VP Dave, J Joseph Microorganisms 7 (10), 411, 2019 | 29 | 2019 |
| Endophthalmitis and concurrent or delayed-onset rhegmatogenous retinal detachment managed with pars plana vitrectomy, intravitreal antibiotics, and silicone oil VP Dave, A Pathengay, N Relhan, P Sharma, S Jalali, RR Pappuru, ... Ophthalmic Surgery, Lasers and Imaging Retina 48 (7), 546-551, 2017 | 28 | 2017 |
| Does ophthalmic-grade silicone oil possess antimicrobial properties? VP Dave, J Joseph, P Jayabhasker, RR Pappuru, A Pathengay, T Das Journal of Ophthalmic Inflammation and Infection 9, 1-6, 2019 | 25 | 2019 |
| Clinical presentations, microbiology and management outcomes of culture-proven endogenous endophthalmitis in India VP Dave, A Pathengay, B Panchal, A Jindal, A Datta, S Sharma, ... Indian Journal of Ophthalmology 68 (5), 834-839, 2020 | 24 | 2020 |
| Endoscopic vitrectomy in endophthalmitis: initial experience of 33 cases at a tertiary eye care center VP Dave, RR Pappuru, M Tyagi, A Pathengay, T Das Clinical Ophthalmology (Auckland, NZ) 13, 243, 2019 | 24 | 2019 |
| Herbal ethosomal gel containing luliconazole for productive relevance in the field of biomedicine V Dave, N Bhardwaj, N Gupta, K Tak 3 Biotech 10 (3), 97, 2020 | 23 | 2020 |
| Role of diagnostic endoscopy in posterior segment evaluation for definitive prognostication in eyes with corneal opacification RRR Pappuru, M Tyagi, RM Paulose, VP Dave, T Das, J Chhablani, ... American Journal of Ophthalmology 176, 9-14, 2017 | 23 | 2017 |
| Endophthalmitis progressing to panophthalmitis: clinical features, demographic profile, and factors predicting outcome RR Pappuru, VP Dave, A Pathengay, S Gangakhedkar, S Sharma, ... Seminars in Ophthalmology 33 (5), 671-674, 2018 | 22 | 2018 |
